延长复苏虽致代谢恶化,体外心肺复苏仍改善难治性室颤/室速院外心脏骤停生存
该回顾性研究比较了明尼苏达大学ECPR方案治疗的160例难治性室颤/室速院外心脏骤停患者与ALPS试验中654例标准CPR患者。结果显示ECPR组神经功能良好生存率更高(33%对23%,P=0.01),且CPR持续时间更长(60分钟对35分钟,P<0.001)。在CPR持续<60分钟的每个时间区间,ECPR组神经功能良好生存率均更高,但两组生存率均随CPR时间延长而下降。ECPR组中CPR 20-29分钟者全部(8/8)神经功能良好生存,而ALPS组同时间仅24%(24/102)。ALPS组CPR≥40分钟无神经功能良好生存者,ECPR组50-59分钟为25%(9/36),≥60分钟为19%。延长CPR伴随pH下降、乳酸和动脉二氧化碳分压升高及左室壁增厚。
要点
- ECPR组神经功能良好生存率高于标准CPR组(33%对23%,P=0.01)
- CPR<60分钟各时间区间ECPR组神经功能良好生存率均更高
- CPR持续时间延长与两组神经功能良好生存率下降相关
核心结论
- ECPR与CPR持续时间<60分钟时所有时间区间的神经功能良好生存改善相关,尽管存在严重的进行性代谢紊乱。
- CPR持续时间仍是生存的关键决定因素。
研究设计与样本
- 回顾性研究,比较160例接受明尼苏达大学ECPR方案的难治性室颤/室速院外心脏骤停成人患者与654例ALPS试验胺碘酮组标准CPR成人患者。
主要发现
- ECPR组神经功能良好生存率33%,ALPS组23%(P=0.01)。
- ECPR组平均CPR持续时间60分钟,ALPS组35分钟(P<0.001)。
- CPR<60分钟各时间区间ECPR组神经功能良好生存率显著高于ALPS组。
- ECPR组CPR 20-29分钟者8/8神经功能良好生存,ALPS组同时间24%(24/102)。
- ALPS组CPR≥40分钟无神经功能良好生存者;ECPR组50-59分钟为25%(9/36),≥60分钟为19%。
关键数值与推荐
- 神经功能良好生存率:ECPR组33%对ALPS组23%(P=0.01)。
- 平均CPR持续时间:ECPR组60分钟对ALPS组35分钟(P<0.001)。
- CPR 20-29分钟神经功能良好生存:ECPR组8/8对ALPS组24%(24/102)。
- CPR 50-59分钟神经功能良好生存:ECPR组25%(9/36)。
- CPR≥60分钟神经功能良好生存:ECPR组19%。
临床怎么用
- 对于难治性室颤/室速院外心脏骤停患者,ECPR可改善CPR<60分钟时的神经功能良好生存。
- CPR持续时间延长时ECPR的生存获益仍存在但逐渐下降,需综合评估复苏时间。
局限性
- 回顾性研究设计,ECPR组与ALPS组为历史对照比较。
- ALPS试验为胺碘酮组标准CPR患者,非同期随机对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The likelihood of neurologically favorable survival declines with prolonged resuscitation. However, the ability of extracorporeal cardiopulmonary resuscitation (ECPR) to modulate this decline is unknown. Our aim was to examine the effects of resuscitation duration on survival and metabolic profile in patients who undergo ECPR for refractory ventricular fibrillation/ventricular tachycardia out-of-hospital cardiac arrest. METHODS: We retrospectively evaluated survival in 160 consecutive adults with refractory ventricular fibrillation/ventricular tachycardia out-of-hospital cardiac arrest treated with the University of Minnesota (UMN) ECPR protocol (transport with ongoing cardiopulmonary resuscitation [CPR] to the cardiac catheterization laboratory for ECPR) compared with 654 adults who had received standard CPR in the amiodarone arm of the ALPS trial (Amiodarone, Lidocaine, or Placebo Study). We evaluated the metabolic changes and rate of survival in relation to duration of CPR in UMN-ECPR patients. RESULTS: Neurologically favorable survival was significantly higher in UMN-ECPR patients versus ALPS patients (33% versus 23%; P=0.01) overall. The mean duration of CPR was also significantly longer for UMN-ECPR patients versus ALPS patients (60 minutes versus 35 minutes; P<0.001). Analysis of the effect of CPR duration on neurologically favorable survival demonstrated significantly higher neurologically favorable survival for UMN-ECPR patients compared with ALPS patients at each CPR duration interval <60 minutes; however, longer CPR duration was associated with a progressive decline in neurologically favorable survival in both groups. All UMN-ECPR patients with 20 to 29 minutes of CPR (8 of 8) survived with neurologically favorable status compared with 24% (24 of 102) of ALPS patients with the same duration of CPR. There were no neurologically favorable survivors in the ALPS cohort with CPR ≥40 minutes, whereas neurologically favorable survival was 25% (9 of 36) for UMN-ECPR patients with 50 to 59 minutes of CPR and 19% with ≥60 minutes of CPR. Relative risk of mortality or poor neurological function was significantly reduced in UMN-ECPR patients with CPR duration ≥60 minutes. Significant metabolic changes included decline in pH, increased lactic acid and arterial partial pressure of carbon dioxide, and thickened left ventricular wall with prolonged professional CPR. CONCLUSIONS: ECPR was associated with improved neurologically favorable survival at all CPR durations <60 minutes despite severe progressive metabolic derangement. However, CPR duration remains a critical determinate of survival.
引用
- Bartos JA, Grunau B, Carlson C, et al. Improved Survival With Extracorporeal Cardiopulmonary Resuscitation Despite Progressive Metabolic Derangement Associated With Prolonged Resuscitation. Circulation. 2020. PMID: 31896278. doi:10.1161/CIRCULATIONAHA.119.042173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。